Ellsworth Advisors »

Immunovant shares owned by Ellsworth Advisors

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Ellsworth Advisors from 13F filings

Historical chart of Ellsworth Advisors investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Ellsworth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Ellsworth Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $802k 32k 24.84

More positions owned by Ellsworth Advisors

Spdr Gold Tr Gold Shs (GLD)
Harbor Etf Trust Harbor Commodity (HGER)
NVIDIA Corporation (NVDA)
First Tr Exchange-traded First Tr Enh New (FTSM)
Johnson & Johnson (JNJ)
Apple (AAPL)
Amgen (AMGN)
Enterprise Products Partners (EPD)
Chevron Corporation (CVX)
Alphabet Cap Stk Cl C (GOOG)
Petroleo Brasileiro S A Sponsored Adr (PBR)
Vertiv Holdings Com Cl A (VRT)
Eli Lilly & Co. (LLY)
Altria (MO)
Pepsi (PEP)

View all positions for Ellsworth Advisors

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
BlackRock
Baker Bros. Advisors
T. Rowe Price Investment Management
State Street Corporation
Rtw Investments
Two Seas Capital
Alpine Partners VI
ADAR1 Capital Management
Point72 Asset Management
Perceptive Advisors
Woodline Partners
Geode Capital Management

View all funds holding Immunovant